Latest Share Chat

REMOVE ADS

Astrazeneca Share News (AZN)

Astrazeneca Information

Share Price Information for Astrazeneca (AZN)

Share Price is delayed by 15 minutes

Get Live Data

14,274.00 -44.00 (-0.31%)

Bid:

14,270.00

Ask:

14,274.00

Spread: 4.00 (0.028%)

Market Cap: £221.37b

Last checked at -

Intraday Astrazeneca Share Chart

REMOVE ADS

Astrazeneca News

LONDON BRIEFING: BHP dam trial begins in UK; Hollywood Bowl confident

(Alliance News) - London's FTSE 100 is called to open largely flat on Monday, in a tentative start to the week, despite rate cuts in China.

AstraZeneca's nerve damage treatment recommended for approval in EU

(Sharecast News) - Pharma titan AstraZeneca has announced that its Wainzua nerve damage treatment has been recommended for approval in the EU.

Hutchmed reports positive results from AstraZeneca lung cancer collaboration

(Sharecast News) - Hutchmed China announced positive results from its Savannah phase two trial on Wednesday, which studied the combination of 'Tagriss...

TOP NEWS: AstraZeneca's Tagrisso plus Orpathys shows promising results

(Alliance News) - Hutchmed China Ltd on Wednesday said that Tagrisso plus Orpathys showed a high clinically meaningful response rate in patients with ...

LONDON MARKET MIDDAY: Stocks go red as cautious sentiment prevails

(Alliance News) - Stock prices in London were lower at midday on Monday, as investors wait for a number of inflationary prints later in the week.

TOP NEWS: Enhertu by AstraZeneca, Daiichi wins new approval in China

(Alliance News) - AstraZeneca PLC on Monday said that its antibody drug conjugate Enhertu won another approval in China.

LONDON MARKET OPEN: Stocks defy China data to start green

(Alliance News) - Stock prices in London opened just about higher on Monday morning, inching up despite disappointing data from China, and reports of ...

Roche CEO: breast cancer pill could enter $12 bln market if trials succeed

MANNHEIM, Germany, Oct 9 (Reuters) - Roche's experimental oral drug for breast cancer giredestrant could enter a market worth at least 10 billion Sw...